| Pharmaceutical active ingredients: |
| Glucagon recombinant |
| Available forms, composition and doses of Fragment: |
| N / A |
| Fragment medical category: |
| Human:Agents affecting metabolismGlycogenolytic agents |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| H04AA01 - Glucagon |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Unidentified Pharmaceutical Company |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Fouramine D | P-Phenylenediamine | Unidentified Pharmaceutical Company |
| Fouramine RS | Resorcinol | Unidentified Pharmaceutical Company |
| Fourrine | P-Phenylenediamine | Unidentified Pharmaceutical Company |
| Foxglove | Digitalis | Unidentified Pharmaceutical Company |
| Fracine | Nitrofurazone | Unidentified Pharmaceutical Company |
| Franocide | Diethylcarbamazine | Unidentified Pharmaceutical Company |
| Franozan | Diethylcarbamazine | Unidentified Pharmaceutical Company |
| Franroze | Tegafur | Unidentified Pharmaceutical Company |
| Franyl | Furosemide | Unidentified Pharmaceutical Company |
| Fraquinol | Neomycin | Unidentified Pharmaceutical Company |